Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Ilag

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The EMBO Journal|May 1, 1995
Functional analysis of mutant neurotrophins deficient in low-affinity binding reveals a role for p75LNGFR in NT-4 signallingM Rydén, J Murray-Rust, D Glass, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 studyT C Blevins, D Dahl, J Rosenstock, et al.
Nature|January 9, 1992
Atomic structure of single-stranded DNA bacteriophage phi X174 and its functional implicationsR McKenna, D Xia, P Willingmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Pan-neurotrophin 1: a genetically engineered neurotrophic factor displaying multiple specificities in peripheral neurons in vitro and in vivoL L Ilag, R Curtis, D Glass, et al.
Pediatric Endocrinology Reviews : PER|March 26, 2020
Eli Lilly and Company Insulins - A Century of InnovationJ K Malone, J H Jr Anderson, H A Wolpert, et al.
Diabetes, Obesity & Metabolism|October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitusL L Ilag, M A Deeg, T Costigan, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The EMBO Journal|May 1, 1995
Functional analysis of mutant neurotrophins deficient in low-affinity binding reveals a role for p75LNGFR in NT-4 signallingM Rydén, J Murray-Rust, D Glass, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 studyT C Blevins, D Dahl, J Rosenstock, et al.
Nature|January 9, 1992
Atomic structure of single-stranded DNA bacteriophage phi X174 and its functional implicationsR McKenna, D Xia, P Willingmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Pan-neurotrophin 1: a genetically engineered neurotrophic factor displaying multiple specificities in peripheral neurons in vitro and in vivoL L Ilag, R Curtis, D Glass, et al.
Pediatric Endocrinology Reviews : PER|March 26, 2020
Eli Lilly and Company Insulins - A Century of InnovationJ K Malone, J H Jr Anderson, H A Wolpert, et al.
Diabetes, Obesity & Metabolism|October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitusL L Ilag, M A Deeg, T Costigan, et al.
Pageof 4